{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:53:01Z","timestamp":1790419981885,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP142426"],"award-info":[{"award-number":["MOP142426"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardiac Arrhythmia Network of Canada","award":["SRG-15-P01-001"],"award-info":[{"award-number":["SRG-15-P01-001"]}]},{"name":"Cardiac Arrhythmia Network of Canada","award":["SRG-17-P27-001"],"award-info":[{"award-number":["SRG-17-P27-001"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000445"],"award-info":[{"award-number":["UL1 TR000445"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.autneu.2018.04.008","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T13:04:02Z","timestamp":1525439042000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Pharmacotherapy for postural tachycardia syndrome"],"prefix":"10.1016","volume":"215","author":[{"given":"Amanda J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-3785","authenticated-orcid":false,"given":"Satish R.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2018.04.008_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2018.02.005","article-title":"Cognitive and psychological issues in postural tachycardia syndrome","author":"Arnold","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2018.04.008_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2018.02.005","article-title":"Postural tachycardia syndrome \u2013 diagnosis, physiology, and prognosis","author":"Arnold","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2018.04.008_bb0015","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1212\/WNL.0b013e318293e310","article-title":"Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study","volume":"80","author":"Arnold","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2018.04.008_bb0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5664\/jcsm.5806","article-title":"Objective sleep assessments in patients with postural tachycardia syndrome using overnight polysomnograms","volume":"12","author":"Bagai","year":"2016","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.autneu.2018.04.008_bb0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5664\/jcsm.28110","article-title":"Sleep disturbances and diminished quality of life in postural tachycardia syndrome","volume":"7","author":"Bagai","year":"2011","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.autneu.2018.04.008_bb0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/pace.12118","article-title":"Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients","volume":"36","author":"Benezet-Mazuecos","year":"2013","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2018.04.008_bb0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/17843286.2016.1200816","article-title":"Long-term methylphenidate intake in chronic fatigue syndrome","volume":"71","author":"Blockmans","year":"2016","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.autneu.2018.04.008_bb0045","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2012.06.031","article-title":"Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation","volume":"60","author":"Cappato","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0050","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.hrthm.2012.05.002","article-title":"Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome","volume":"9","author":"Coffin","year":"2012","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.autneu.2018.04.008_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40256-017-0248-x","article-title":"Ivabradine in postural orthostatic tachycardia syndrome: preliminary experience in children","volume":"18","author":"Delle Donne","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.autneu.2018.04.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2018.05.001","article-title":"Cell disorders and postural orthostatic tachycardia syndrome","author":"Doherty","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2018.04.008_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0975-3583.85261","article-title":"Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients","volume":"2","author":"Fares","year":"2011","journal-title":"J. Cardiovasc. Dis. Res."},{"issue":"1985","key":"10.1016\/j.autneu.2018.04.008_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1152\/japplphysiol.00367.2014","article-title":"Acute volume loading and exercise capacity in postural tachycardia syndrome","volume":"117","author":"Figueroa","year":"2014","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10286-011-0130-x","article-title":"Fludrocortisone improves nausea in children with orthostatic intolerance (OI)","volume":"21","author":"Fortunato","year":"2011","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7326\/0003-4819-104-3-298","article-title":"Idiopathic hypovolemia","volume":"104","author":"Fouad","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.autneu.2018.04.008_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02281112","article-title":"Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone","volume":"10","author":"Freitas","year":"2000","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0090","article-title":"Exercise and non-pharmacological approaches to POTS","author":"Fu","year":"2017","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2018.04.008_bb0095","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.jacc.2010.02.043","article-title":"Cardiac origins of the postural orthostatic tachycardia syndrome","volume":"55","author":"Fu","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.111.172262","article-title":"Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome","volume":"58","author":"Fu","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2018.04.008_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1378\/chest.83.2.436","article-title":"Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia","volume":"83","author":"Gaffney","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.autneu.2018.04.008_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hrthm.2015.12.012","article-title":"The international POTS registry: evaluating the efficacy of an exercise training intervention in a community setting","volume":"13","author":"George","year":"2016","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.autneu.2018.04.008_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2018.04.004","article-title":"Evaluation of postural tachycardia syndrome (POTS)","author":"Goodman","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2018.04.008_bb0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02291387","article-title":"Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome","volume":"10","author":"Gordon","year":"2000","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1755-5922.12067","article-title":"Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial","volume":"32","author":"Green","year":"2014","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.autneu.2018.04.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000395","article-title":"Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome","volume":"2","author":"Green","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.autneu.2018.04.008_bb0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1540-8159.1996.tb03367.x","article-title":"The use of methylphenidate in the treatment of refractory neurocardiogenic syncope","volume":"19","author":"Grubb","year":"1996","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0140","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","volume":"1","author":"Hauser","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.autneu.2018.04.008_bb0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10286-006-0373-0","article-title":"Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine","volume":"16","author":"Hoeldtke","year":"2006","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0150","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10286-007-0436-x","article-title":"Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR","volume":"17","author":"Hoeldtke","year":"2007","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0002-9343(99)80230-7","article-title":"Treatment of orthostatic tachycardia with erythropoietin","volume":"99","author":"Hoeldtke","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2018.04.008_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0002-9343(97)00133-2","article-title":"Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system","volume":"103","author":"Jacob","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2018.04.008_bb0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.CIR.96.2.575","article-title":"Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia","volume":"96","author":"Jacob","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2018.04.008_bb0170","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1540-8159.2011.03047.x","article-title":"Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience","volume":"34","author":"Kanjwal","year":"2011","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MJT.0b013e3181e28156","article-title":"Use of octreotide in the treatment of refractory orthostatic intolerance","volume":"19","author":"Kanjwal","year":"2012","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.autneu.2018.04.008_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MJT.0b013e3181dd21d2","article-title":"Use of methylphenidate in the treatment of patients suffering from refractory postural tachycardia syndrome","volume":"19","author":"Kanjwal","year":"2012","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.autneu.2018.04.008_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MJT.0b013e3181ef621a","article-title":"Erythropoietin in the treatment of postural orthostatic tachycardia syndrome","volume":"19","author":"Kanjwal","year":"2012","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.autneu.2018.04.008_bb0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2018.04.008_bb0195","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/JCP.0000000000000221","article-title":"Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome: a randomized, placebo-controlled trial","volume":"34","author":"Kpaeyeh","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0200","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune basis for postural tachycardia syndrome","volume":"3","author":"Li","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.autneu.2018.04.008_bb0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.autneu.2018.04.008_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fneur.2014.00118","article-title":"Sleep disturbances and autonomic dysfunction in patients with postural orthostatic tachycardia syndrome","volume":"5","author":"Mallien","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/europace\/euq390","article-title":"Single centre experience of ivabradine in postural orthostatic tachycardia syndrome","volume":"13","author":"McDonald","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.autneu.2018.04.008_bb0220","first-page":"218","article-title":"Beneficial effects of oral rehydration solution on orthostatic intolerance","volume":"22","author":"Medow","year":"2012","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2018.05.002","article-title":"Sleep disorders in postural tachycardia syndrome","author":"Miglis","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2018.04.008_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10286-015-0331-9","article-title":"Sleep disorders in patients with postural tachycardia syndrome","volume":"26","author":"Miglis","year":"2016","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0235","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00246-015-1274-6","article-title":"Intravenous hydration for management of medication-resistant orthostatic intolerance in the adolescent and young adult","volume":"37","author":"Moak","year":"2016","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0240","first-page":"269","article-title":"Differential effects of dietary salt on blood volume regulation in postural tachycardia syndrome and healthy subjects","volume":"23","author":"Nwazue","year":"2013","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1176\/appi.psy.44.1.38","article-title":"A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome","volume":"44","author":"Olson","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.autneu.2018.04.008_bb0250","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.sleep.2015.08.003","article-title":"Characterisation of sleep disturbances in postural orthostatic tachycardia syndrome: a polysomnography-based study","volume":"16","author":"Pengo","year":"2015","journal-title":"Sleep Med."},{"key":"10.1016\/j.autneu.2018.04.008_bb0255","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/CIRCULATIONAHA.112.144501","article-title":"Postural tachycardia syndrome (POTS)","volume":"127","author":"Raj","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2018.04.008_bb0260","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/01.CIR.0000160356.97313.5D","article-title":"Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome","volume":"111","author":"Raj","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2018.04.008_bb0265","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1161\/CIRCULATIONAHA.104.497594","article-title":"Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome","volume":"111","author":"Raj","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2018.04.008_bb0270","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCULATIONAHA.108.846501","article-title":"Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more","volume":"120","author":"Raj","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2018.04.008_bb0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.2008.144360","article-title":"Psychiatric profile and attention deficits in postural tachycardia syndrome","volume":"80","author":"Raj","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autneu.2018.04.008_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MAJ.0b013e318063c6c0","article-title":"Blood volume perturbations in the postural tachycardia syndrome","volume":"334","author":"Raj","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autneu.2018.04.008_bb0285","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1113\/jphysiol.2003.043182","article-title":"Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans","volume":"551","author":"Ray","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10286-013-0212-z","article-title":"What is brain fog? An evaluation of the symptom in postural tachycardia syndrome","volume":"23","author":"Ross","year":"2013","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2018.04.008_bb0295","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/CS20130222","article-title":"A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome","volume":"126","author":"Ross","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.autneu.2018.04.008_bb0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/HYPERTENSIONAHA.114.04204","article-title":"Prospects for droxidopa in neurogenic orthostatic hypotension","volume":"65","author":"Ross","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2018.04.008_bb0305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.285.1.52","article-title":"Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial","volume":"285","author":"Rowe","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.autneu.2018.04.008_bb0310","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10840-017-0225-y","article-title":"Effects of intermittent intravenous saline infusions in patients with medication-refractory postural tachycardia syndrome","volume":"48","author":"Ruzieh","year":"2017","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0315","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/MJT.0000000000000468","article-title":"Droxidopa in the treatment of postural orthostatic tachycardia syndrome","volume":"24","author":"Ruzieh","year":"2017","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.autneu.2018.04.008_bb0320","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/pace.13182","article-title":"Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience","volume":"11","author":"Ruzieh","year":"2017","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0325","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.autneu.2018.04.008_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2016.04.030","article-title":"Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial","volume":"68","author":"Sheldon","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","article-title":"Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders","volume":"45","author":"Shibao","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2018.04.008_bb0340","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1673","article-title":"Pediatric disorders of orthostatic intolerance","volume":"141","author":"Stewart","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.autneu.2018.04.008_bb0345","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/01.CIR.0000040999.00692.F3","article-title":"Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance","volume":"106","author":"Stewart","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2018.04.008_bb0350","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1540-8159.1993.tb01708.x","article-title":"Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope","volume":"16","author":"Susmano","year":"1993","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.autneu.2018.04.008_bb0355","article-title":"Autoimmunity in POTS","author":"Vernino","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2018.04.008_bb0360","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2018.04.008_bb0365","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.HYP.0000156540.25707.af","article-title":"Endurance exercise training in orthostatic intolerance: a randomized, controlled trial","volume":"45","author":"Winker","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2018.04.008_bb0370","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.psychres.2012.09.007","article-title":"Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study","volume":"207","author":"Young","year":"2013","journal-title":"Psychiatry Res."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070218300250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070218300250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:12:45Z","timestamp":1761567165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070218300250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":74,"alternative-id":["S1566070218300250"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2018.04.008","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for postural tachycardia syndrome","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2018.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}